Annual Cash & Cash Equivalents
$119.71 M
+$20.87 M+21.11%
December 31, 2024
Summary
- As of March 12, 2025, CSTL annual cash & cash equivalents is $119.71 million, with the most recent change of +$20.87 million (+21.11%) on December 31, 2024.
- During the last 3 years, CSTL annual cash & cash equivalents has fallen by -$209.92 million (-63.68%).
- CSTL annual cash & cash equivalents is now -70.79% below its all-time high of $409.85 million, reached on December 31, 2020.
Performance
CSTL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$119.71 M
+$24.75 M+26.06%
December 31, 2024
Summary
- As of March 12, 2025, CSTL quarterly cash and cash equivalents is $119.71 million, with the most recent change of +$24.75 million (+26.06%) on December 31, 2024.
- Over the past year, CSTL quarterly cash and cash equivalents has increased by +$20.87 million (+21.11%).
- CSTL quarterly cash and cash equivalents is now -70.79% below its all-time high of $409.85 million, reached on December 31, 2020.
Performance
CSTL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CSTL Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.1% | +21.1% |
| 3 y3 years | -63.7% | +21.1% |
| 5 y5 years | +21.1% | +21.1% |
CSTL Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -63.7% | +21.1% | -63.7% | +44.3% |
| 5 y | 5-year | -70.8% | +21.1% | -70.8% | +44.3% |
| alltime | all time | -70.8% | +9776.2% | -70.8% | +2572.7% |
Castle Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $119.71 M(+21.1%) | $119.71 M(+26.1%) |
| Sep 2024 | - | $94.96 M(+11.0%) |
| Jun 2024 | - | $85.57 M(+3.2%) |
| Mar 2024 | - | $82.95 M(-16.1%) |
| Dec 2023 | $98.84 M(-19.6%) | $98.84 M(+8.4%) |
| Sep 2023 | - | $91.22 M(-4.9%) |
| Jun 2023 | - | $95.87 M(-16.5%) |
| Mar 2023 | - | $114.82 M(-6.6%) |
| Dec 2022 | $122.95 M(-62.7%) | $122.95 M(-8.4%) |
| Sep 2022 | - | $134.18 M(-50.9%) |
| Jun 2022 | - | $273.17 M(-11.6%) |
| Mar 2022 | - | $309.02 M(-6.3%) |
| Dec 2021 | $329.63 M | $329.63 M(-9.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $363.18 M(-1.4%) |
| Jun 2021 | - | $368.34 M(-9.5%) |
| Mar 2021 | - | $406.98 M(-0.7%) |
| Dec 2020 | $409.85 M(+314.6%) | $409.85 M(+123.9%) |
| Sep 2020 | - | $183.05 M(+1.8%) |
| Jun 2020 | - | $179.76 M(+82.2%) |
| Mar 2020 | - | $98.65 M(-0.2%) |
| Dec 2019 | $98.84 M(+2106.9%) | $98.84 M(+4.6%) |
| Sep 2019 | - | $94.47 M(+440.8%) |
| Jun 2019 | - | $17.47 M(+7.6%) |
| Mar 2019 | - | $16.23 M(+262.4%) |
| Dec 2018 | $4.48 M(+269.5%) | $4.48 M |
| Dec 2017 | $1.21 M | - |
FAQ
- What is Castle Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Castle Biosciences?
- What is Castle Biosciences annual cash & cash equivalents year-on-year change?
- What is Castle Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Castle Biosciences?
- What is Castle Biosciences quarterly cash and cash equivalents year-on-year change?
What is Castle Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of CSTL is $119.71 M
What is the all time high annual cash & cash equivalents for Castle Biosciences?
Castle Biosciences all-time high annual cash & cash equivalents is $409.85 M
What is Castle Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, CSTL annual cash & cash equivalents has changed by +$20.87 M (+21.11%)
What is Castle Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CSTL is $119.71 M
What is the all time high quarterly cash and cash equivalents for Castle Biosciences?
Castle Biosciences all-time high quarterly cash and cash equivalents is $409.85 M
What is Castle Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, CSTL quarterly cash and cash equivalents has changed by +$20.87 M (+21.11%)